Evidence map›Paper›PMID 26040627›Full record

Trial reportAlimentary pharmacology & therapeutics2015

Randomised clinical study: Aspergillus niger-derived enzyme digests gluten in the stomach of healthy volunteers.

B N Salden, V Monserrat, F J Troost, M J Bruins, L Edens, R Bartholomé, G R Haenen, B Winkens, F Koning, A A Masclee

Registry-linked trialOpen access · hybridAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Alimentary pharmacology & therapeutics, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT01335503 (Effect of AN-PEP Enzyme on Gastrointestinal Breakdown of Gluten), which is not on this map. Cited by 35 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed, 1 pooled it
5.2field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01335503 nacompletednot on this map

Effect of AN-PEP Enzyme on Gastrointestinal Breakdown of Gluten

TypeinterventionalSponsorDSM Food SpecialtiesRan2011 to 2012Enrolled12ConditionsGluten DigestionArmsAN-PEP
3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 1 synthesis or guideline pooled it, 78 citations in OpenAlex.

  1. Pooled it
  2. Effect ofWorld journal of gastroenterology · 2024
    Trial
  3. Trial
  4. Trial
  5. Article
  6. Article
  7. Review
  8. Review
  9. Review
  10. Celiac Disease: Beyond Diet and Food Awareness.Foods (Basel, Switzerland) · 2025
    Review
  11. Review
  12. Article
  13. Innovative concepts in diet therapies in disorders of gut-brain interaction.JGH open : an open access journal of gastroenterology and hepatology · 2024
    Review
  14. Review
  15. Review
  16. New Developments in Celiac Disease Treatment.International journal of molecular sciences · 2023
    Review
  17. Replacing the Burden of the Gluten Free Diet: Then, Now, and the Future.International journal of molecular sciences · 2022
    Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

B N SaldenDivision of Gastroenterology-Hepatology, Department of Internal Medicine, NUTRIM, Maastricht University Medical Center (MUMC+), Maastricht, The Netherlands.
V MonserratDepartment of Immunohematology and Blood Transfusion, Leiden University Medical Centre (LUMC), Leiden, The Netherlands.
F J TroostDivision of Gastroenterology-Hepatology, Department of Internal Medicine, NUTRIM, Maastricht University Medical Center (MUMC+), Maastricht, The Netherlands.
M J BruinsDSM Biotechnology Centre, Delft, The Netherlands.
L EdensDSM Biotechnology Centre, Delft, The Netherlands.
R BartholoméDepartment of Pharmacology and Toxicology, CARIM, Maastricht University, Maastricht, The Netherlands.
G R HaenenDepartment of Pharmacology and Toxicology, CARIM, Maastricht University, Maastricht, The Netherlands.
B WinkensDepartment of Methodology and Statistics, CAPHRI, Maastricht University Medical Center (MUMC+), Maastricht, The Netherlands.
F KoningDepartment of Immunohematology and Blood Transfusion, Leiden University Medical Centre (LUMC), Leiden, The Netherlands.
A A MascleeDivision of Gastroenterology-Hepatology, Department of Internal Medicine, NUTRIM, Maastricht University Medical Center (MUMC+), Maastricht, The Netherlands.
Maastricht University · NLDSM (Netherlands) · NLLeiden University Medical Center · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAspergillus niger prolyl endoprotease (AN-PEP) efficiently degrades gluten molecules into non-immunogenic peptides in vitro.

aimTo assess the efficacy of AN-PEP on gluten degradation in a low and high calorie meal in healthy subjects.

methodsIn this randomised, double-blind, placebo-controlled, cross-over study 12 healthy volunteers attended to four test days. A liquid low or high calorie meal (4 g gluten) with AN-PEP or placebo was administered into the stomach. Via a triple-lumen catheter gastric and duodenal aspirates were sampled, and polyethylene glycol (PEG)-3350 was continuously infused. Acetaminophen in the meals tracked gastric emptying time. Gastric and duodenal samples were used to calculate 240-min area under the curve (AUC0-240 min ) of ?-gliadin concentrations. Absolute ?-gliadin AUC0-240 min was calculated using duodenal PEG-3350 concentrations.

resultsAN-PEP lowered α-gliadin concentration AUC0-240 min, compared to placebo, from low and high calorie meals in stomach (low: 35 vs. 389 μg × min/mL; high: 53 vs. 386 μg × min/mL; P < 0.001) and duodenum (low: 7 vs. 168 μg × min/mL; high: 4 vs. 32 μg × min/mL; P < 0.001) and absolute α-gliadin AUC0-240 min in the duodenum from low (2813 vs. 31 952 μg × min; P < 0.001) and high (2553 vs. 13 095 μg × min; P = 0.013) calorie meals. In the placebo group, the high compared to low calorie meal slowed gastric emptying and lowered the duodenal α-gliadin concentration AUC0-240 min (32 vs. 168 μg × min/mL; P = 0.001).

conclusionsAN-PEP significantly enhanced gluten digestion in the stomach of healthy volunteers. Increasing caloric density prolonged gastric residence time of the meal. Since AN-PEP already degraded most gluten from low calorie meals, no incremental effect was observed by increasing meal caloric density. ClinicalTrials.gov, Number: NCT01335503; www.trialregister.nl, Number: NTR2780.

Indexed as

AcetaminophenAdultAspergillus nigerCross-Over StudiesDigestionDouble-Blind MethodDuodenumEnergy IntakeFemaleGastric EmptyingGastric MucosaGliadinGlutensHumansMaleYoung AdultAcetaminophenGliadinGlutens

Identifiers

PMID26040627
PMCPMC5032996
OpenAlexW1605330909

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.